Case number 2019-2418
Bayer HealthCare LLC v. Baxalta Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | BAYER HEALTHCARE LLC v. BAXALTA INC. [OPINION] [precedential] (0) |
| Apr 7, 2021 | 69 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [767236] [19-2418, 20-1017] [JCP] [Entered: 04/07/2021 11:11 AM] (1) |
| Mar 1, 2021 | 68 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [759126] [19-2418, 20-1017] [JCP] [Entered: 03/01/2021 09:27 AM] (1) |
| Mar 1, 2021 | 67 | OPINION filed for the court by Newman, Circuit Judge; Linn, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. [759125] [19-2418, 20-1017] [JCP] [Entered: 03/01/2021 09:25 AM] (37) |
| Aug 31, 2020 | 66 | Submitted after ORAL ARGUMENT by Edgar Haug for Baxalta Inc., Baxalta US Inc. and Nektar Therapeutics and Bradford J. Badke for Bayer HealthCare LLC. Panel: Judge: Newman , Judge: Linn , Judge: Stoll.Oral Argument Audio available here. [718495] [JAB] [Entered: 08/31/2020 12:35 PM] (0) |
| Aug 17, 2020 | 65 | Clerk's letter to Appellants Baxalta Inc., Baxalta US Inc., Appellee Nektar Therapeutics and Cross-Appellant Bayer HealthCare LLC regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [715247] [JAB] [Entered: 08/17/2020 01:45 PM] (0) |
| Aug 17, 2020 | 64 | Response to notice of oral argument from the Cross-Appellant Bayer HealthCare LLC. Service: 08/17/2020 by email. [715171] [19-2418] [Bradford Badke] [Entered: 08/17/2020 11:22 AM] (2) |
| Aug 17, 2020 | 63 | Response to notice of oral argument from the Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics. Service: 08/17/2020 by email. [715166] [19-2418] [Edgar Haug] [Entered: 08/17/2020 11:04 AM] (1) |
| Jul 21, 2020 | 62 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2009A. Case scheduled August 31, 2020. Response to Notice of Oral Argument due: 08/17/2020. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [708861] [JAB] [Entered: 07/21/2020 11:47 AM] (1) |
| Jul 20, 2020 | 61 | 6 paper copies of the Corrected Opening Brief [30], Response and Reply Brief [40], and Joint Appendix (Vol. I-V) [49] received from Baxalta Inc., Baxalta US Inc., and Nektar Therapeutics. [708649] [MJL] [Entered: 07/20/2020 04:45 PM] (0) |
| Jul 20, 2020 | 60 | 6 paper copies of the Opening and Response Brief [34] and Reply Brief [41] received from Bayer HealthCare LLC. [708638] [MJL] [Entered: 07/20/2020 04:27 PM] (0) |
| Jul 16, 2020 | 59 | Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before July 23, 2020. See Administrative Order No. 20-01 (Mar. 20, 2020). [707930] [MMA] [Entered: 07/16/2020 09:32 AM] (0) |
| Jun 5, 2020 | 58 | The following conflict dates submitted by Edgar Haug for Baxalta Inc., Baxalta US Inc. and Nektar Therapeutics have been accepted by the court: 10/05/2020, 10/06/2020, 10/07/2020, 10/08/2020, 10/09/2020. [699421] [JAB] [Entered: 06/05/2020 09:11 AM] (0) |
| Jun 5, 2020 | 57 | The following conflict dates submitted by Bradford J. Badke for Bayer HealthCare LLC have been accepted by the court: 09/02/2020, 09/03/2020, 09/04/2020, 10/05/2020, 10/06/2020, 10/07/2020, 10/08/2020, 10/09/2020, 11/06/2020. [699418] [JAB] [Entered: 06/05/2020 09:05 AM] (0) |
| Jun 4, 2020 | 56 | Notice from Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics regarding conflicts with oral argument. Service: 06/04/2020 by email. [699368] [19-2418] [Edgar Haug] [Entered: 06/04/2020 08:49 PM] (4) |
| Jun 4, 2020 | 55 | Notice from Cross-Appellant Bayer HealthCare LLC regarding conflicts with oral argument. Service: 06/04/2020 by email. [699366] [19-2418] [Bradford Badke] [Entered: 06/04/2020 08:18 PM] (4) |
| May 28, 2020 | 54 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [697462] [LMN] [Entered: 05/28/2020 10:16 AM] (1) |
| May 15, 2020 | 53 | MODIFIED ENTRY: CORRECTED BRIEF FILED for Appellants Baxalta Inc. and Baxalta US Inc. Number of Pages: 85. Service: 05/15/2020 by email. [695115]--[Edited 05/20/2020 by MMA - Reason: compliance review complete] [Edgar Haug] [Entered: 05/15/2020 07:46 PM] (244) |
| May 15, 2020 | 52 | Notice of Correction to Doc No. [30] for Appellants Baxalta Inc. and Baxalta US Inc.. Service: 05/15/2020 by email. [695114] [19-2418] [Edgar Haug] [Entered: 05/15/2020 07:42 PM] (2) |
| May 11, 2020 | 50 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Baxalta Inc. and Baxalta US Inc., Opening Brief [30], is not in compliance with the rules of this court (see attached). Compliant document is due on 05/18/2020. Service as of this date by the Clerk of Court. [693618] [LMN] [Entered: 05/11/2020 04:07 PM] (1) |
| May 8, 2020 | 51 | Corresponding briefs on CD-ROM received from Baxalta Inc. and Baxalta US Inc. Number of copies: 6. [694404] [MJL] [Entered: 05/14/2020 08:51 AM] (0) |
| May 8, 2020 | 49 | MODIFIED ENTRY: APPENDIX FILED for Baxalta Inc., Baxalta US Inc. and Nektar Therapeutics. Number of Pages: 1591. Service: 05/08/2020 by email. [693351] --[Edited 05/28/2020 by LMN - compliance review complete] [Edgar Haug] [Entered: 05/08/2020 08:58 PM] (1591) |
| May 8, 2020 | 48 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Baxalta Inc., Baxalta US Inc., Appellee Nektar Therapeutics and Cross-Appellant Bayer HealthCare LLC. Service: 05/08/2020 by email. [693311] [19-2418] [Edgar Haug] [Entered: 05/08/2020 05:16 PM] (3) |
| May 8, 2020 | 47 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Cross-Appellant Bayer HealthCare LLC. Service: 05/08/2020 by email. [693139] [19-2418] [Bradford Badke] [Entered: 05/08/2020 11:55 AM] (3) |
| May 7, 2020 | 46 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics. Service: 05/07/2020 by email. [692973] [19-2418] [Edgar Haug] [Entered: 05/07/2020 06:27 PM] (2) |
| May 7, 2020 | 45 | Notice of intent to file corresponding briefs on CD-ROM for Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics. Service: 05/07/2020 by email. [692970] [19-2418] [Edgar Haug] [Entered: 05/07/2020 06:25 PM] (3) |
| May 7, 2020 | 44 | Notice of intent to file corresponding briefs on CD-ROM for Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics. Service: 05/07/2020 by email. [692968] [19-2418] [Edgar Haug] [Entered: 05/07/2020 06:20 PM] (2) |
| May 7, 2020 | 43 | **TEXT ONLY** ORDER granting motion to withdraw counsel Angus Chen and Elizabeth Murphy [42] filed by Appellee Nektar Therapeutics and Appellant Baxalta Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [692864] [MMA] [Entered: 05/07/2020 02:38 PM] (0) |
| May 4, 2020 | 42 | MOTION of Appellant Baxalta Inc. and Appellee Nektar Therapeutics to withdraw counsel Angus Chen and Elizabeth Murphy [Consent: unopposed]. Service: 05/04/2020 by email. [691900] [19-2418] [Edgar Haug] [Entered: 05/04/2020 11:32 AM] (5) |
| May 1, 2020 | 41 | MODIFIED ENTRY: REPLY BRIEF FILED for Cross-Appellant Bayer HealthCare LLC. Number of Pages: 17. Service: 05/01/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [691797]--[Edited 05/04/2020 by MMA - Reason: compliance review complete] [Bradford Badke] [Entered: 05/01/2020 08:26 PM] (25) |
| Apr 9, 2020 | 40 | MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED for Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics. Number of Pages: 75. Service: 04/09/2020 by email. [685745]--[Edited 04/10/2020 by MMA - Reason: compliance review complete] [Nicholas Giove] [Entered: 04/09/2020 05:19 PM] (89) |
| Apr 9, 2020 | 39 | Notice of Correction to Doc No. [37] for Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics. Service: 04/09/2020 by email. [685744] [19-2418] [Nicholas Giove] [Entered: 04/09/2020 05:17 PM] (2) |
| Apr 9, 2020 | 38 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics, Reply Brief [37], is not in compliance with the rules of this court (see attached). Compliant brief due on 04/16/2020. Service as of this date by the Clerk of Court. [685578] [MMA] [Entered: 04/09/2020 12:01 PM] (1) |
| Apr 7, 2020 | 36 | Entry of appearance for Kaitlin M. Abrams as of counsel for Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics. Service: 04/07/2020 by email. [684828] [19-2418] [Edgar Haug] [Entered: 04/07/2020 01:25 PM] (1) |
| Apr 7, 2020 | 37 | FILED from Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics. Title: REPLY BRIEF. Service: 04/07/2020 by email. [684857] [19-2418] This brief is non-compliant. See Doc. No. [38] [Nicholas Giove] [Entered: 04/07/2020 01:53 PM] (89) |
| Apr 3, 2020 | 35 | Entry of appearance for Erika V. Selli as of counsel for Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics. Service: 04/03/2020 by email. [684140] [19-2418] [Edgar Haug] [Entered: 04/03/2020 05:03 PM] (1) |
| Feb 20, 2020 | 34 | MODIFIED ENTRY: BRIEF FILED for Cross-Appellant Bayer HealthCare LLC. Number of Pages: 74. Service: 02/20/2020 by email. [673006]--[Edited 03/03/2020 by MMA - Reason: compliance review complete] [Bradford Badke] [Entered: 02/20/2020 11:34 PM] (87) |
| Feb 20, 2020 | 33 | Entry of appearance for Ryan C. Morris as of counsel for Cross-Appellant Bayer HealthCare LLC. Service: 02/20/2020 by email. [672926] [19-2418] [Ryan Morris] [Entered: 02/20/2020 03:58 PM] (2) |
| Feb 7, 2020 | 32 | ORDER granting motion to set briefing schedule [31]. (See order for details) Service as of this date by the Clerk of Court. [669547] [NL] [Entered: 02/07/2020 05:19 PM] (2) |
| Jan 29, 2020 | 31 | MOTION of Cross-Appellant Bayer HealthCare LLC to extend the time to 02/20/2020 to file the principal and response briefs. [Consent: unopposed]. Service: 01/29/2020 by email. [667131] [19-2418] [Bradford Badke] [Entered: 01/29/2020 06:34 PM] (6) |
| Dec 10, 2019 | 30 | MODIFIED ENTRY: BRIEF FILED for Appellants Baxalta Inc. and Baxalta US Inc. Number of Pages: 85. Service: 12/10/2019 by email. [655334]--[Edited 12/19/2019 by MMA - Reason: compliance review complete] The document is non-compliant. See Doc No. [50] [Jonathan Herstoff] [Entered: 12/10/2019 02:38 PM] (224) |
| Dec 6, 2019 | 29 | Notice from Appellants Baxalta Inc. and Baxalta US Inc. Response to Bayer Healthcare LLC's November 18, 2019 Notice. Service: 12/06/2019 by email. [654719] [19-2418] [Jonathan Herstoff] [Entered: 12/06/2019 04:06 PM] (31) |
| Nov 18, 2019 | 28 | Notice from Cross-Appellant Bayer HealthCare LLC regarding postjudgment motions. Service: 11/18/2019 by email. [650230] [19-2418] [Bradford Badke] [Entered: 11/18/2019 03:16 PM] (3) |
| Nov 15, 2019 | 27 | Entry of appearance for Jonathan A. Herstoff as of counsel for Appellants Baxalta Inc., Baxalta US Inc. and Appellee Nektar Therapeutics. Service: 11/15/2019 by email. [649672] [19-2418] [Jonathan Herstoff] [Entered: 11/15/2019 02:03 PM] (2) |
| Nov 12, 2019 | 26 | ORDER granting motion [25] to the following extent: Appellants' principal brief is due no later than December 10, 2019; Cross-Appellant's principal and response brief is due no later than February 10, 2020; the combined response and reply brief of Appellants and response brief of Appellee is due no later than March 23, 2020; and Cross-Appellant's reply brief is due no later than April 13, 2020. Service as of this date by the Clerk of Court. [648724] [LMS] [Entered: 11/12/2019 03:54 PM] (2) |
| Oct 28, 2019 | 25 | MOTION of Appellants Baxalta Inc. and Baxalta US Inc. to extend the time to 12/10/2019 to file the principal brief., to set briefing schedule [Consent: unopposed]. Service: 10/28/2019 by email. [645067] [19-2418] [Edgar Haug] [Entered: 10/28/2019 11:07 AM] (9) |
| Oct 21, 2019 | 24 | Docketing Statement for the Appellee Nektar Therapeutics. Service: 10/21/2019 by email. [643641] [19-2418] [Edgar Haug] [Entered: 10/21/2019 08:02 PM] (4) |
| Oct 21, 2019 | 23 | Certificate of Interest for Appellee Nektar Therapeutics. Service: 10/21/2019 by email. [643640] [19-2418] [Edgar Haug] [Entered: 10/21/2019 07:53 PM] (3) |
| Oct 21, 2019 | 22 | Entry of appearance for Elizabeth Murphy as of counsel for Appellee Nektar Therapeutics. Service: 10/21/2019 by email. [643638] [19-2418] [Edgar Haug] [Entered: 10/21/2019 07:40 PM] (2) |
| Oct 21, 2019 | 21 | Entry of appearance for Nicholas F. Giove as of counsel for Appellee Nektar Therapeutics. Service: 10/21/2019 by email. [643637] [19-2418] [Edgar Haug] [Entered: 10/21/2019 07:36 PM] (2) |
| Oct 21, 2019 | 20 | Entry of appearance for Angus Chen as of counsel for Appellee Nektar Therapeutics. Service: 10/21/2019 by email. [643636] [19-2418] [Edgar Haug] [Entered: 10/21/2019 07:33 PM] (2) |
| Oct 21, 2019 | 19 | Entry of appearance for Edgar H. Haug as principal counsel for Appellee Nektar Therapeutics. Service: 10/21/2019 by email. [643635] [19-2418] [Edgar Haug] [Entered: 10/21/2019 07:31 PM] (2) |
| Oct 21, 2019 | 18 | Certificate of Interest for Cross-Appellant Bayer HealthCare LLC. Service: 10/21/2019 by email. [643623] [19-2418] [Bradford Badke] [Entered: 10/21/2019 06:05 PM] (3) |
| Oct 21, 2019 | 17 | Docketing Statement for the Cross-Appellant Bayer HealthCare LLC. Service: 10/21/2019 by email. [643622] [19-2418] [Bradford Badke] [Entered: 10/21/2019 06:04 PM] (4) |
| Oct 11, 2019 | 16 | Entry of appearance for Joshua J. Fougere as of counsel for Cross-Appellant Bayer HealthCare LLC. Service: 10/11/2019 by email. [641899] [19-2418] [Bradford Badke] [Entered: 10/11/2019 02:44 PM] (2) |
| Oct 11, 2019 | 15 | Entry of appearance for Paul Zegger as of counsel for Cross-Appellant Bayer HealthCare LLC. Service: 10/11/2019 by email. [641898] [19-2418] [Bradford Badke] [Entered: 10/11/2019 02:42 PM] (2) |
| Oct 11, 2019 | 14 | Entry of appearance for Sona De as of counsel for Cross-Appellant Bayer HealthCare LLC. Service: 10/11/2019 by email. [641895] [19-2418] [Bradford Badke] [Entered: 10/11/2019 02:39 PM] (2) |
| Oct 11, 2019 | 13 | Entry of appearance for Ching-Lee Fukuda as of counsel for Cross-Appellant Bayer HealthCare LLC. Service: 10/11/2019 by email. [641893] [19-2418] [Bradford Badke] [Entered: 10/11/2019 02:35 PM] (2) |
| Oct 7, 2019 | 12 | Official caption revised to reflect 20-1017 as the Cross-Appeal. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [640597] [MMA] [Entered: 10/07/2019 12:12 PM] (0) |
| Oct 7, 2019 | 11 | Note to file: The following cases are associated:19-2418 (Lead) with 20-1017 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [640595] [19-2418, 20-1017] [MMA] [Entered: 10/07/2019 12:10 PM] (0) |
| Oct 4, 2019 | 10 | Certificate of Interest for Appellee Bayer HealthCare LLC. Service: 10/04/2019 by email. [640466] [19-2418] [Bradford Badke] [Entered: 10/04/2019 09:15 PM] (3) |
| Oct 4, 2019 | 9 | Docketing Statement for the Appellee Bayer HealthCare LLC. Service: 10/04/2019 by email. [640465] [19-2418] [Bradford Badke] [Entered: 10/04/2019 09:12 PM] (4) |
| Oct 4, 2019 | 8 | Entry of appearance for Bradford J. Badke as principal counsel for Appellee Bayer HealthCare LLC. Service: 10/04/2019 by email. [640463] [19-2418] [Bradford Badke] [Entered: 10/04/2019 09:09 PM] (2) |
| Oct 4, 2019 | 7 | Certificate of Interest for Appellants Baxalta Inc. and Baxalta US Inc.. Service: 10/04/2019 by email. [640455] [19-2418] [Edgar Haug] [Entered: 10/04/2019 05:16 PM] (3) |
| Oct 4, 2019 | 6 | Docketing Statement for the Appellants Baxalta Inc. and Baxalta US Inc.. Service: 10/04/2019 by email. [640454] [19-2418] [Edgar Haug] [Entered: 10/04/2019 05:13 PM] (4) |
| Oct 4, 2019 | 5 | Entry of appearance for Elizabeth J. Murphy as of counsel for Appellants Baxalta Inc. and Baxalta US Inc.. Service: 10/04/2019 by email. [640451] [19-2418] [Edgar Haug] [Entered: 10/04/2019 05:11 PM] (2) |
| Oct 4, 2019 | 4 | Entry of appearance for Nicholas F. Giove as of counsel for Appellants Baxalta Inc. and Baxalta US Inc.. Service: 10/04/2019 by email. [640450] [19-2418] [Edgar Haug] [Entered: 10/04/2019 05:09 PM] (2) |
| Oct 4, 2019 | 3 | Entry of appearance for Angus Chen as of counsel for Appellants Baxalta Inc. and Baxalta US Inc.. Service: 10/04/2019 by email. [640449] [19-2418] [Edgar Haug] [Entered: 10/04/2019 05:07 PM] (2) |
| Oct 4, 2019 | 2 | Entry of appearance for Edgar H. Haug as principal counsel for Appellants Baxalta Inc. and Baxalta US Inc.. Service: 10/04/2019 by email. [640448] [19-2418] [Edgar Haug] [Entered: 10/04/2019 05:03 PM] (2) |
| Sep 20, 2019 | 1 | Appeal docketed. Received: 09/19/2019. [636995]Entry of Appearance due 10/04/2019. Certificate of Interest is due on 10/04/2019. Docketing Statement due 10/04/2019. Appellants' brief is due 11/19/2019. [MMA] [Entered: 09/20/2019 10:56 AM] (87) |
